High-molecular-weight kininogen

High-molecular-weight kininogen (HMWK), also known as kininogen-1, is a protein that plays a critical role in blood coagulation, inflammation, and blood pressure regulation. It is one of the kininogens, a group of proteins that are precursors to the kinins, which are potent vasodilators and contribute to the permeability of blood vessels. HMWK is a key component of the Kallikrein-kinin system, which is involved in physiological processes such as pain induction, blood pressure control, and smooth muscle contraction.

Structure and Function

HMWK is a large, multifunctional glycoprotein synthesized in the liver. It circulates in the plasma at a concentration of approximately 90 µg/mL. The protein is composed of three distinct domains: a heavy chain, a light chain, and a bradykinin peptide sequence. The heavy chain is involved in the binding to cell surfaces and other proteins, such as prekallikrein and Factor XI, facilitating their activation. The light chain contains the bradykinin peptide, which is released upon cleavage by kallikrein.

The primary function of HMWK is to serve as a substrate for the generation of bradykinin, a process that is initiated upon the activation of the kallikrein-kinin system. Bradykinin, in turn, exerts multiple biological effects, including vasodilation, increased vascular permeability, smooth muscle contraction, and pain sensation.

Role in Coagulation and Inflammation

HMWK is intricately involved in the regulation of both coagulation and inflammation. In the coagulation cascade, it acts as a cofactor for the activation of Factor XI by prekallikrein, which ultimately leads to the formation of a blood clot. This interaction is essential for the intrinsic pathway of blood coagulation.

In the context of inflammation, HMWK, through the generation of bradykinin, contributes to the increased vascular permeability and edema associated with inflammatory responses. Bradykinin's effects are mediated through its interaction with specific G protein-coupled receptors on the surface of endothelial cells, leading to the release of nitric oxide and prostacyclin, which are potent vasodilators.

Clinical Significance

Alterations in the levels or function of HMWK can lead to various pathological conditions. Deficiency in HMWK, although rare, can result in a bleeding disorder due to impaired coagulation. Conversely, excessive activation of the kallikrein-kinin system, leading to increased bradykinin levels, can cause hereditary angioedema, characterized by recurrent episodes of severe swelling.

Moreover, HMWK and the kallikrein-kinin system have been implicated in the pathogenesis of several cardiovascular diseases, including hypertension and myocardial infarction. The system's role in these conditions is attributed to its effects on blood pressure regulation and vascular homeostasis.

Research Directions

Research on HMWK and the kallikrein-kinin system continues to uncover new insights into their roles in health and disease. Potential therapeutic interventions targeting this system are being explored for the treatment of inflammatory and cardiovascular diseases, as well as for the management of pain and edema.

See Also

• Kinin
• Kallikrein
• Bradykinin
• Coagulation
• Inflammation

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian